WHO calls on Pfizer to make its COVID capsule extra obtainable

GENEVA (AP) — The pinnacle of the World Well being Group referred to as on Pfizer to make its COVID-19 remedy extra extensively obtainable in poorer nations, saying Tuesday that the pharmaceutical firm’s deal permitting generic producers to make the drug was inadequate.

WHO Director-Normal Tedros Adhanom Ghebreyesus mentioned throughout a information briefing that Pfizer’s remedy was nonetheless too costly. He famous that the majority nations in Latin America had no entry to Pfizer’s drug, Paxlovid, which has been proven to chop the chance of COVID-19 hospitalization or demise by as much as 90%.

“We stay involved that low- and middle-income nations stay unable to entry antivirals,” Tedros mentioned,

The WHO chief warned that the unequal distribution of COVID-19 medicine might finally mirror the grossly disproportionate distribution of coronavirus vaccines.

For instance, whereas nations reminiscent of Britain have vaccinated greater than 70% of their populations, fewer than 16% of individuals in poor nations have acquired a single dose.

Pfizer signed an agreement in November with the U.N.-backed Medicines Patent Pool to permit different drugmakers to make generic copies of its pill, to be used in 95 nations. Some giant nations that suffered devastating COVID-19 outbreaks, like Brazil, weren’t included.

Tedros mentioned the deal doesn’t go far sufficient and referred to as for Pfizer to raise its geographic restrictions on the place the generic model of Paxlovid is perhaps used, in addition to to make the capsule more cost effective for growing nations.

The U.S. paid about $500 for every course of Pfizer’s remedy, which consists of three capsules taken twice a day for 5 days. Its worth in growing nations has not but been confirmed.

WHO’s chief scientist Dr. Soumya Swaminathan mentioned a lot of the world’s provide of Pfizer’s drug had already been booked by wealthy nations, just like how they hoarded the overwhelming majority of final 12 months’s coronavirus vaccines.

She applauded Pfizer’s settlement to let different drugmakers produce its drug, however famous that manufacturing wouldn’t begin till subsequent 12 months. Swaminathan additionally appealed to Pfizer to drop its requirement for some growing nations to imagine product legal responsibility in case there are any issues as soon as it’s rolled out.


Comply with AP’s protection of the pandemic at https://apnews.com/hub/coronavirus-pandemic


Conversations are opinions of our readers and are topic to the Code of Conduct. The Star doesn’t endorse these opinions.


Leave a Reply